ScinoPharm Taiwan (Taiwan) Technical Analysis

1789 Stock  TWD 23.50  0.15  0.63%   
As of the 23rd of November, ScinoPharm Taiwan has the Variance of 1.07, risk adjusted performance of (0.08), and Coefficient Of Variation of (944.30). ScinoPharm Taiwan technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate ScinoPharm Taiwan mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if ScinoPharm Taiwan is priced more or less accurately, providing market reflects its prevalent price of 23.5 per share.

ScinoPharm Taiwan Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ScinoPharm, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ScinoPharm
  
ScinoPharm Taiwan's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
ScinoPharm Taiwan technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ScinoPharm Taiwan technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ScinoPharm Taiwan trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

ScinoPharm Taiwan Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ScinoPharm Taiwan volatility. High ATR values indicate high volatility, and low values indicate low volatility.

ScinoPharm Taiwan Trend Analysis

Use this graph to draw trend lines for ScinoPharm Taiwan. You can use it to identify possible trend reversals for ScinoPharm Taiwan as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ScinoPharm Taiwan price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

ScinoPharm Taiwan Best Fit Change Line

The following chart estimates an ordinary least squares regression model for ScinoPharm Taiwan applied against its price change over selected period. The best fit line has a slop of   0.03  , which may suggest that ScinoPharm Taiwan market price will keep on failing further. It has 122 observation points and a regression sum of squares at 38.5, which is the sum of squared deviations for the predicted ScinoPharm Taiwan price change compared to its average price change.

About ScinoPharm Taiwan Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ScinoPharm Taiwan on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ScinoPharm Taiwan based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ScinoPharm Taiwan price pattern first instead of the macroeconomic environment surrounding ScinoPharm Taiwan. By analyzing ScinoPharm Taiwan's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ScinoPharm Taiwan's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ScinoPharm Taiwan specific price patterns or momentum indicators. Please read more on our technical analysis page.

ScinoPharm Taiwan November 23, 2024 Technical Indicators

Most technical analysis of ScinoPharm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ScinoPharm from various momentum indicators to cycle indicators. When you analyze ScinoPharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for ScinoPharm Stock Analysis

When running ScinoPharm Taiwan's price analysis, check to measure ScinoPharm Taiwan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScinoPharm Taiwan is operating at the current time. Most of ScinoPharm Taiwan's value examination focuses on studying past and present price action to predict the probability of ScinoPharm Taiwan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScinoPharm Taiwan's price. Additionally, you may evaluate how the addition of ScinoPharm Taiwan to your portfolios can decrease your overall portfolio volatility.